Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity: Preliminary Study, Randomized Controlled Trials

NCT05889026 is registered in ClinicalTrials.gov with Korea University Guro Hospital as lead sponsor.

NCT NCT05889026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05889026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity: Preliminary Study, Randomized Controlled Trials
Lead sponsor
Korea University Guro Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 6, 2020
Completion date
September 8, 2021
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemiplegia, spastic, muscle spasticity, stroke